Become A Clinical Trial Volunteer - Touch Another Life
Uh-oh! This study is no longer available.

We're sorry, but the study or condition you’re looking for is no longer available. You can search all currently enrolling studies or contact us if you have any questions.

Metastatic Castration-Resistant Prostate Cancer

Medical Condition

Prostate Cancer


PMG Research of DuPage Medical Group


18 or older




PMG Research and DuPage Mmedical Clinic are looking for men to participate in a research study evaluating the combination of abiraterone (FDA-approved) with olaparib for Metastatic Castration-Resistant Prostate Cancer (mCRPC).

This research study may be an option if you:

·         Have been diagnosed with mCRPC

·         Have not received any cytotoxic chemotherapy, new hormonal agents, or other systemic treatment for mCRPC

·         Are a candidate for abiraterone therapy

·         Have no history of uncontrolled pituitary, adrenal dysfunction, high blood pressure, or evidence of significant cardiovascular disease

Other criteria apply. Qualified participants will receive all study-related care and study medication at no cost.




Patient Commitment Duration

Varies with patient response and outcome

Patient Compensation

Financial reimbursement for travel costs will be provided. 

Number of visits in study

Varies with patient response and outcome

Apply for this Study Now